Cargando…

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants

PURPOSE: Provincial public drug formularies in Canada have different mechanisms for reimbursement of direct-acting oral anticoagulants (DOACs). We investigate how these differences influence DOAC utilization and expenditure across the country. METHODS: We conducted a population-based, cross-sectiona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Lulu, Tadrous, Mina, Knowles, Sandra, Mamdani, Muhammad, Paterson, J. Michael, Juurlink, David, Gomes, Tara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Longwoods Publishing 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749525/ https://www.ncbi.nlm.nih.gov/pubmed/29274228 http://dx.doi.org/10.12927/hcpol.2017.25321

Ejemplares similares

Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2019)

Interprovincial Variation of Psychotropic Prescriptions Dispensed to Older Canadian Adults
por: Black, Cody D., et al.
Publicado: (2018)

Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study
por: Tadrous, Mina, et al.
Publicado: (2018)

The Burden of Opioid-Related Mortality in the United States
por: Gomes, Tara, et al.
Publicado: (2018)

Trends in Opioid Toxicity–Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021
por: Gomes, Tara, et al.
Publicado: (2023)

Measuring the Burden of Opioid-related Mortality in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada
por: Gomes, Tara, et al.
Publicado: (2018)

Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study
por: Pasricha, Sachin V., et al.
Publicado: (2018)

Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study
por: Gomes, Tara, et al.
Publicado: (2022)

Varenicline and Risk of Self-Harm: A Nested Case-Control Study
por: Tadrous, Mina, et al.
Publicado: (2016)

Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults
por: Tadrous, Mina, et al.
Publicado: (2021)

The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation
por: Sholzberg, Michelle, et al.
Publicado: (2016)

Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada
por: Martins, Diana, et al.
Publicado: (2022)

Impact of a publicly-funded pharmacare program policy on benzodiazepine dispensing among children and youth: a population-based natural experiment
por: Antoniou, Tony, et al.
Publicado: (2023)

Impact of a Publicly-Funded Pharmacare Program on Prescription Stimulant use Among Children and Youth: A Population-Based Observational Natural Experiment
por: Antoniou, Tony, et al.
Publicado: (2023)

Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide
por: Mamdani, Muhammad, et al.
Publicado: (2019)

Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis
por: Antoniou, Tony, et al.
Publicado: (2021)

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
por: Antoniou, Tony, et al.
Publicado: (2018)

Adherence to antipsychotic laboratory monitoring guidelines in children and youth: a population-based study
por: Antoniou, Tony, et al.
Publicado: (2023)

The Risk of Ventricular Dysrhythmia or Sudden Death in Patients Receiving Serotonin Reuptake Inhibitors With Methadone: A Population-Based Study
por: Antoniou, Tony, et al.
Publicado: (2022)

Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study
por: Antoniou, Tony, et al.
Publicado: (2023)

Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
por: Antoniou, Tony, et al.
Publicado: (2023)

Fixed-dose combination antihypertensive medications, adherence, and clinical outcomes: A population-based retrospective cohort study
por: Verma, Amol A., et al.
Publicado: (2018)

Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US–Canada border
por: Gomes, Tara, et al.
Publicado: (2012)

Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
por: Antoniou, Tony, et al.
Publicado: (2023)

Extent of a valsartan drug shortage and its effect on antihypertensive drug use in the Canadian population: a national cross-sectional study
por: Fenna, Jennifer, et al.
Publicado: (2021)

Impact of a Publicly Funded Herpes Zoster Immunization Program on the Burden of Disease in Ontario, Canada: A Population-based Study
por: Martins, Diana, et al.
Publicado: (2020)

Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: Population-based cohort study
por: Tadrous, Mina, et al.
Publicado: (2022)

Projected impact of biosimilar substitution policies on drug use and costs in Ontario, Canada: a cross-sectional time series analysis
por: Gomes, Tara, et al.
Publicado: (2021)

The burden of premature opioid-related mortality
por: Gomes, Tara, et al.
Publicado: (2014)

Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits
por: Morrow, Richard L, et al.
Publicado: (2019)

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study
por: Gomes, Tara, et al.
Publicado: (2022)

Trends in opioid use and dosing among socio-economically disadvantaged patients
por: Gomes, Tara, et al.
Publicado: (2011)

High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study
por: Spooner, Luke, et al.
Publicado: (2016)

Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study
por: Gomes, Tara, et al.
Publicado: (2017)

Extended-release nifedipine and the risk of intestinal obstruction: a population-based study
por: Juurlink, David N, et al.
Publicado: (2014)

The Impact of Drug Reimbursement Policy on Rates of Testosterone Replacement Therapy among Older Men
por: Piszczek, Jolanta, et al.
Publicado: (2014)

Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series Analysis
por: Shakeri, Ahmad, et al.
Publicado: (2021)

Prior Authorization to Manage Drug Utilization and Costs
por: Curtiss, Frederic R.
Publicado: (2003)

Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: A cross-sectional time-series analysis
por: Chang, Ann, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nml4vadnscl3uga0ik2km6d5li